Pfizer Says it’s Eyeing a $110 to $130 List Price for COVID-19 Vaccine in U.S.

Pfizer Inc. has revealed the price it is eyeing in the U.S. for its adult COVID-19 vaccine on the commercial market. The Pfizer-BioNTech vaccine would potentially cost between $110 and $130 for a single-dose vial in the U.S., Pfizer’s Angela Lukin said in an analyst and investor call.  That cost will reflect its “cost-effectiveness,” including “increased costs” associated with transitioning from a multi-dose vial to a single-dose and to commercial distribution as well as the value it has “brought to society,” according to Lukin. 

RELATED: How Pfizer won the pandemic in profit and influence

Categories: Coronavirus

Tagged as: ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s